Our study demonstrated that decreased TP63 expression is a negative and independent prognostic factor in breast cancer, and the TAp63 mRNA level was down-regulated in MDA-MB-231, HCC1954, and MCF-7 cells in laboratory tests, consistent with previous reports. The gene discussed is TP63; the disease is breast carcinoma.